Guangdong Association Of Clinical Trials

This study tests the drug lorlatinib in people with a specific type of lung cancer (ALK-positive) that has spread to the brain or the lining of the brain and spinal cord. The goal is to see how well the drug shrinks these brain tumors. About 41 adults will take part, and the stud…

This phase 3 study tests a targeted drug called almonertinib in people with a specific type of advanced lung cancer (EGFR-mutant, stage III) that cannot be removed by surgery. After initial treatment, doctors use a sensitive blood test (MRD) to decide if more treatment is needed.…

This study tests whether the immunotherapy drug nivolumab, alone or with chemotherapy, can shrink early-stage non-small cell lung cancer before surgery and help prevent it from coming back after. About 316 people with stage II or IIIA lung cancer that can be removed surgically ar…